To delineate the potential molecular mechanisms underlying the effects of erdafitinib on HCC cells, the transcriptome sequencing was conducted to assess the genome-wide effect of erdafitinib on gene e
To determine the drug target of lenvatinib, RNAseq was used to evaluate the transcriptome differences between lenvatinib-treated MHCC-97H cells and their parental counterparts.
